MMP10 and triple-negative breast carcinoma: It also inhibits human triple-negative breast cancer cells’ metastatic potential by modulating matrix metalloproteinase-10 (MMP-10), epithelial to mesenchymal transition, and PI3K/Akt signaling pathway [41].